Sejahteraraya Anugrahjaya Tbk (SRAJ) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.025x

Based on the latest financial reports, Sejahteraraya Anugrahjaya Tbk (SRAJ) has a cash flow conversion efficiency ratio of 0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp36.75 Billion ≈ $2.15 Million USD) by net assets (Rp1.45 Trillion ≈ $84.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Sejahteraraya Anugrahjaya Tbk fund operations to measure how many days the company can operate on defensive assets alone.

Sejahteraraya Anugrahjaya Tbk - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Sejahteraraya Anugrahjaya Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sejahteraraya Anugrahjaya Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sejahteraraya Anugrahjaya Tbk ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
G Mining Ventures Corp.
TO:GMIN
0.069x
Public Power Corporation S.A.
AT:PPC
0.052x
AURUBIS AG UNSP.ADR 1/2
F:NDA1
-0.002x
Shenghe Resources Holding Co Ltd
SHG:600392
0.024x
Yunnan Chihong Zinc&Germanium Co Ltd
SHG:600497
0.018x
UL Solutions Inc.
NYSE:ULS
0.164x
Repligen Corporation
NASDAQ:RGEN
0.023x
Cinda Securities Co. Ltd. A
SHG:601059
0.075x

Annual Cash Flow Conversion Efficiency for Sejahteraraya Anugrahjaya Tbk (2009–2024)

The table below shows the annual cash flow conversion efficiency of Sejahteraraya Anugrahjaya Tbk from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Sejahteraraya Anugrahjaya Tbk.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp1.83 Trillion
≈ $107.42 Million
Rp273.25 Billion
≈ $16.01 Million
0.149x +395.10%
2023-12-31 Rp1.86 Trillion
≈ $108.84 Million
Rp55.92 Billion
≈ $3.28 Million
0.030x -72.89%
2022-12-31 Rp1.90 Trillion
≈ $111.05 Million
Rp210.47 Billion
≈ $12.33 Million
0.111x -36.44%
2021-12-31 Rp1.93 Trillion
≈ $112.94 Million
Rp336.79 Billion
≈ $19.73 Million
0.175x +226.60%
2020-12-31 Rp1.75 Trillion
≈ $102.82 Million
Rp93.88 Billion
≈ $5.50 Million
0.054x +26.04%
2019-12-31 Rp1.78 Trillion
≈ $104.10 Million
Rp75.42 Billion
≈ $4.42 Million
0.042x +381.67%
2018-12-31 Rp1.84 Trillion
≈ $107.98 Million
Rp16.24 Billion
≈ $951.59K
0.009x -6.01%
2017-12-31 Rp1.62 Trillion
≈ $95.21 Million
Rp15.24 Billion
≈ $892.73K
0.009x +0.15%
2016-12-31 Rp1.72 Trillion
≈ $101.02 Million
Rp16.14 Billion
≈ $945.82K
0.009x -40.66%
2015-12-31 Rp1.02 Trillion
≈ $59.48 Million
Rp16.01 Billion
≈ $938.40K
0.016x +11.46%
2014-12-31 Rp1.15 Trillion
≈ $67.10 Million
Rp16.21 Billion
≈ $949.82K
0.014x +122.80%
2013-12-31 Rp1.25 Trillion
≈ $73.00 Million
Rp7.92 Billion
≈ $463.80K
0.006x -85.35%
2012-12-31 Rp654.08 Billion
≈ $38.33 Million
Rp28.37 Billion
≈ $1.66 Million
0.043x -39.97%
2011-12-31 Rp649.42 Billion
≈ $38.05 Million
Rp46.92 Billion
≈ $2.75 Million
0.072x +29.35%
2010-12-31 Rp556.74 Billion
≈ $32.62 Million
Rp31.10 Billion
≈ $1.82 Million
0.056x +184.97%
2009-12-31 Rp494.99 Billion
≈ $29.00 Million
Rp9.70 Billion
≈ $568.50K
0.020x --

About Sejahteraraya Anugrahjaya Tbk

JK:SRAJ Indonesia Medical Care Facilities
Market Cap
$7.44 Billion
Rp126.98 Trillion IDR
Market Cap Rank
#2806 Global
#11 in Indonesia
Share Price
Rp10375.00
Change (1 day)
-5.68%
52-Week Range
Rp3760.00 - Rp17200.00
All Time High
Rp17200.00
About

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. The company operates and manages hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, liver center, oncology center, orthopedic center, spine and arthroplasty center, obstetrics and gynecology center, internal medicine and pulmonology, ped… Read more